Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 27;13(1):4940.
doi: 10.1038/s41598-023-32176-5.

Natural history and predictors for progression in pediatric keratoconus

Affiliations

Natural history and predictors for progression in pediatric keratoconus

Rosalia Antunes-Foschini et al. Sci Rep. .

Abstract

We studied the demographic and clinical predictors associated with keratoconus progression in a pediatric population. Retrospective cohort study. We evaluated 305 eyes without previous surgeries from 168 patients, 9 to < 18 years old, and with a minimum 36-month follow-up in a hospital corneal ambulatory. We used Kaplan-Meyer survival curves; the dependent variable (main outcome measure) was the interval time (months) until the event, defined as an increase of 1.5 D in the maximum keratometry (Kmax), obtained with Pentacam. We evaluated the predictors: age (< or ≥ 14 years), sex, keratoconus familial history, allergy medical history, and the baseline tomographic parameters: mean keratometry (Km), Kmax (< or ≥ 55 D); and thinnest pachymetry (TP). We used log-rank tests and compared median survival times for right (RE)/left eyes (LE) and better (BE)/worse eyes (WE). A p value < 0.05 was considered significant. The patients' mean ± SD age was 15.1 ± 2.3 years old; 67% were boys, 30% were < 14 years, 15% had keratoconus familial history, and 70% were allergic. The general Kaplan-Meyer curves showed no differences between RE/LE or BE/WE. RE with allergy and LE with Kmax ≥ 55 D had smaller survival times ((95%CI 9.67-32.1), p 0.031 and (95%CI 10.1-44.1), p 0.042, respectively). For BE and WE, Kmax ≥ 55 D had smaller survival times ((95% CI 6.42- ), p 0.031 and (95%CI 8.75-31.8), p 0.043, respectively). Keratoconus progression was similar between RE/LE and BE/WE. Steepest corneas are predictors of faster progression. Allergy is also a predictor of keratoconus progression in RE.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Examples of patients who were or were not included in this survival analysis. Patient 1: analyzed from time points A (T0) to B; (event or censoring) Patient 2: censored after the first appointment; Patient 3: excluded due to not having the possibility of being evaluated during a minimum period of at least 36 months; Patient 4: analyzed from time points C (T0) to D (censoring); Patients 5 and 6: included.
Figure 2
Figure 2
Pediatric keratoconus: Distribution of the eyes, showing the reasons for exclusion and the final number included.
Figure 3
Figure 3
Kaplan Meyer empirical curves of time until progression, in months. (a) Right and left eyes, overall progression (Right Eyes (n = 156); 88 events; Median of 21.9 CI95% (14.5; 39.7). Left Eyes (n = 149); 76 events; Median of 22.4 CI95% (13.4; 50.0). p value = 0.76); (b) Right eyes, by the presence of allergy (p value 0.032); and (c). Left eyes, by Kmax severity (p value = 0.043).
Figure 4
Figure 4
Better and worse eyes: Kaplan Meyer empirical curves of time until progression, in months. The eye with the highest Km between both eyes was considered the worse eye. Better (n = 136); 72 events; Median of 24.9 CI95% (15.5, 61.1). Worse (n = 136); 77 events; Median of 19.0; CI95% (11.0, 31.8). p value = 0.301.
Figure 5
Figure 5
Better and worse eyes: Kaplan Meyer empirical curves of time until progression, in months, by sex, age, familial history of keratoconus, and the presence of allergy.
Figure 6
Figure 6
Better and worse eyes: Kaplan Meyer empirical curves of time until progression, in months, by Km, (divided into four groups), by Kmax severity (< or ≥ 55D), and by thinnest pachymetry (TP) (divided into four groups).

Similar articles

Cited by

References

    1. Rabinowitz YS. Keratoconus. Surv. Ophthalmol. 1998;42(4):297–319. doi: 10.1016/S0039-6257(97)00119-7. - DOI - PubMed
    1. McGhee CNJ, Kim BZ, Wilson PJ. Contemporary treatment paradigms in keratoconus. Cornea. 2015;34:S16–S23. doi: 10.1097/ICO.0000000000000504. - DOI - PubMed
    1. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am. J. Ophthalmol. 1986;101(3):267–273. doi: 10.1016/0002-9394(86)90817-2. - DOI - PubMed
    1. Chatzis N, Hafezi F. Progression of keratoconus and efficacy of pediatric [corrected] corneal collagen cross-linking in children and adolescents. J. Refract. Surg. 2012;28(11):753–758. doi: 10.3928/1081597X-20121011-01. - DOI - PubMed
    1. Fujimoto H, Maeda N, Shintani A, et al. Quantitative evaluation of the natural progression of keratoconus using three-dimensional optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 2016;57(9):OCT169–OCT175. doi: 10.1167/iovs.15-18650. - DOI - PubMed

Publication types